| Application no. and date | 01300061.7 (espacenet) (Federated) (European Patent Register), 20010105 | | Patent/reg. no. and date | DK/EP 1125582, 20060802 | | Publication date | 20010822 | | Priority no. and date | US 175704 P, 20000112 | | EP pub. no. and date |
EP 1125582 20010822 | | Effective date | | | Applicant/owner | Pfizer Products Inc., Eastern Point Road
Groton,
Connecticut 06340, US | | Applicant ref. no. | P80600967DK00E | | Inventor | Day, Wesley Warren,
Pfizer Global R. & D., Eastern Point Road
Groton,
Connecticut 06340, US,
Lee, Andrew George,
Pfizer Global R. & D., Eastern Point Road
Groton,
Connecticut 06340, US,
Thompson, David Duane,
Pfizer Global R. & D., Eastern Point Road
Groton,
Connecticut 06340, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/40 (2006.01) , A61K 45/06 (2006.01) , A61P 15/10 (2006.01) , A61P 15/12 (2006.01) | | Title | Anvendelse af estrogenagonister/-antagonister til behandling af seksualforstyrrelse | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
